Yuen Terence, Zhang Hantao, Bonin Robert P
Leslie Dan Faculty of Pharmacy (Yuen, Zhang, Bonin), University of Toronto, Toronto.
Purdue Pharma (Canada) (Yuen), Pickering.
Can Pharm J (Ott). 2021 Jan 19;154(2):110-119. doi: 10.1177/1715163520981397. eCollection 2021 Mar-Apr.
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that begins in childhood and often persists into adulthood. ADHD increases the risk of various negative impacts, and pharmacists are well positioned to address these issues in the community.
This survey study aims to first identify pharmacists' ADHD knowledge gaps and experience with ADHD management and to second assess their preferences for continuing education and their experience with sleep-related issues in ADHD.
A survey was sent to Part A Ontario pharmacists with active licenses who opted in to receive research-related emails ( = 6022). Descriptive statistics were used to analyze survey data, while free-form answers were pooled and evaluated for common themes and trends.
A total of 238 complete responses were received. The average self-reported ADHD knowledge was 5.8 ± 1.96 on a 10-point scale. There was no correlation between the number of years of practice as a pharmacist, the number of working hours per week or the location of practice on pharmacists' self-reported knowledge scores. There was a significant difference in self-reported knowledge of ADHD between pharmacists who were not aware of the Canadian ADHD Resource Alliance (CADDRA) guidelines (5.1 ± 2.1) and those who refer to it for standard of care (7.1 ± 1.5). Almost all pharmacists (95%) indicated they could benefit from additional ADHD education, with a strong preference for "online continuing education modules" (81%). The majority of responders considered psychostimulant ADHD medication as the major possible contributor to sleep disturbances (47%) in ADHD, highlighting a need for further education on the inconclusive link between ADHD medication effects on sleep.
The study results raise the concern that pharmacists may require additional ADHD education but also show the lack of awareness of available resources, such as the CADDRA guidelines. 2021;154:xx-xx.
注意力缺陷多动障碍（ADHD）是一种始于童年并常常持续至成年的神经发育障碍。ADHD会增加各种负面影响的风险，药剂师在社区中能够很好地应对这些问题。
这项调查研究旨在首先确定药剂师在ADHD知识方面的差距以及ADHD管理经验，其次评估他们对继续教育的偏好以及他们在ADHD睡眠相关问题方面的经验。
向安大略省持有有效执照且选择接收与研究相关电子邮件的A类药剂师发送了一份调查问卷（n = 6022）。使用描述性统计分析调查数据，同时汇总自由作答的答案并评估其中的共同主题和趋势。
共收到238份完整回复。在10分制量表上，自我报告的ADHD知识平均得分为5.8±1.96。药剂师的自我报告知识得分与从业年限、每周工作时长或执业地点之间没有相关性。不了解加拿大ADHD资源联盟（CADDRA）指南的药剂师（5.1±2.1）与将该指南作为护理标准参考的药剂师（7.1±1.5）在ADHD自我报告知识方面存在显著差异。几乎所有药剂师（95%）表示他们可以从额外的ADHD教育中受益，其中强烈偏好“在线继续教育模块”（81%）。大多数受访者认为精神兴奋剂类ADHD药物是ADHD中睡眠障碍的主要可能促成因素（47%），这凸显了在ADHD药物对睡眠影响的不确定联系方面进行进一步教育的必要性。
研究结果引发了人们对药剂师可能需要额外的ADHD教育的担忧，但也表明他们对现有资源（如CADDRA指南）缺乏认识。2021；154：xx - xx。
